Detalhe da pesquisa
1.
Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir-based dual therapy. Bi-lipid study.
HIV Med;
24(5): 558-567, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36394195
2.
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
BMC Infect Dis;
23(1): 286, 2023 May 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37142994
3.
Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment.
J Infect Dis;
225(2): 287-294, 2022 01 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34166509
4.
Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults.
J Antimicrob Chemother;
77(4): 1125-1132, 2022 03 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35045162
5.
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).
J Antimicrob Chemother;
76(12): 3263-3271, 2021 11 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34459889
6.
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study.
J Antimicrob Chemother;
76(3): 738-742, 2021 02 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33200210
7.
Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns.
EBioMedicine;
88: 104434, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36640455
8.
Ageing with HIV: Challenges and biomarkers.
EBioMedicine;
77: 103896, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35228014
9.
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients.
AIDS;
36(14): 1941-1947, 2022 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35848506
10.
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.
Open Forum Infect Dis;
9(11): ofac610, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36447613
11.
Risks and benefits of reducing the number of drugs to treat HIV-1 infection.
Expert Opin Drug Saf;
20(4): 397-409, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33557651
12.
Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019.
Front Med (Lausanne);
8: 736028, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34568391
13.
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.
Lancet HIV;
8(4): e197-e205, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33794182
14.
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).
EBioMedicine;
55: 102779, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32408111
15.
Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)".
EBioMedicine;
89: 104486, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36806001
16.
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
Clin Epidemiol;
6: 369-77, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25378951
17.
[Systemic secondary AA amyloidosis]. / Amiloidosis sistémica secundaria AA.
Med Clin (Barc);
144(7): 324-30, 2015 Apr 08.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-25023854